A real-time biochemical assay for quantitative analyses of APOBEC-catalyzed DNA deamination

J Biol Chem. 2024 Jun;300(6):107410. doi: 10.1016/j.jbc.2024.107410. Epub 2024 May 23.

Abstract

Over the past decade, the connection between APOBEC3 cytosine deaminases and cancer mutagenesis has become increasingly apparent. This growing awareness has created a need for biochemical tools that can be used to identify and characterize potential inhibitors of this enzyme family. In response to this challenge, we have developed a Real-time APOBEC3-mediated DNA Deamination assay. This assay offers a single-step set-up and real-time fluorescent read-out, and it is capable of providing insights into enzyme kinetics. The assay also offers a high-sensitivity and easily scalable method for identifying APOBEC3 inhibitors. This assay serves as a crucial addition to the existing APOBEC3 biochemical and cellular toolkit and possesses the versatility to be readily adapted into a high-throughput format for inhibitor discovery.

Keywords: APOBEC3; biotechnology; cancer; cytidine deaminase; fluorescence resonance energy transfer (FRET); high-throughput screening (HTS); mutagenesis; protein-DNA interaction; real-time assay; somatic mutations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • APOBEC Deaminases / metabolism
  • Cytidine Deaminase* / metabolism
  • DNA* / chemistry
  • DNA* / metabolism
  • Deamination
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Kinetics

Substances

  • Cytidine Deaminase
  • DNA
  • APOBEC Deaminases
  • APOBEC3 proteins, human
  • Enzyme Inhibitors